Nitrous Oxide Sedara

Description

Nitrous oxide, classified as a non-flammable gas (UN 1070), is recognized under the United States Pharmacopeia (USP) and has a Chemical Abstracts Service (CAS) number of 10024-97-2. This compound is supplied in a content volume of 115 liters. As an oxidizer, it is categorized under the classification of 5.1, indicating its potential to enhance combustion.

Uses and Indications

This drug is indicated for use in medical settings where Nitrous Oxide is deemed appropriate for analgesia or sedation. Administration of Nitrous Oxide may be hazardous or contraindicated; therefore, it is to be used only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrous Oxide. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the requirement for administration by qualified personnel, ensuring that all safety protocols and guidelines are strictly followed. There are no specific teratogenic or nonteratogenic effects associated with this drug noted in the available data.

Dosage and Administration

Administration of Nitrous Oxide is intended for respiratory inhalation only. The active ingredient is provided in a concentration of 990 mL per 1 L.

Due to the potential hazards associated with Nitrous Oxide, it is imperative that this agent is administered solely by or under the supervision of a licensed practitioner who possesses experience in its use and administration.

Healthcare professionals must adhere to the guidelines outlined in the Safety Data Sheet for this product to ensure safe handling and administration practices.

Contraindications

Administration of Nitrous Oxide is contraindicated in situations where safety precautions have not been fully understood or implemented. It should only be administered by or under the supervision of a licensed practitioner experienced in its use, who is knowledgeable about its indications, effects, dosages, methods, frequency, duration of administration, and associated hazards.

The following specific contraindications apply:

• Handling of Nitrous Oxide should not occur until all safety precautions have been thoroughly read and understood.

• Inhalation of the gas should be avoided to prevent respiratory complications.

• Contact with eyes, skin, or clothing must be avoided to prevent irritation or injury.

• Use and storage of Nitrous Oxide should be restricted to outdoor settings or well-ventilated areas to minimize the risk of exposure.

Warnings and Precautions

This product contains a chemical known to the state of California to cause birth defects or other reproductive harm. Healthcare professionals should exercise caution when administering this product, particularly in populations that may be at risk.

Administration of Nitrous Oxide may pose hazards or be contraindicated. It is imperative that this product is used only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrous Oxide. The practitioner must be familiar with the indications, effects, dosages, methods, frequency and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Fire and Safety Precautions Nitrous Oxide is classified as an oxidizer and may cause or intensify fire. It is stored under pressure and may explode if heated. The gas can cause drowsiness or dizziness, displace oxygen, and lead to rapid suffocation. Additionally, exposure may result in frostbite.

To ensure safe handling, it is essential to read and understand all safety precautions prior to use. The product should be kept and stored away from clothing and other combustible materials. Valves and fittings must be kept free from grease and oil. Users should avoid breathing the gas and prevent contact with eyes, skin, or clothing. It is recommended to use and store the product only outdoors or in a well-ventilated area.

In the event of a fire, if it is safe to do so, stop the leak. A backflow preventive device should be utilized in the piping, and only equipment made of compatible materials and rated for cylinder pressure should be used. Equipment must be cleaned for oxygen service. Valves should be opened slowly, and closed after each use and when empty. Protect the product from sunlight when ambient temperatures exceed 52°C (125°F). It is crucial to read and follow the Safety Data Sheet (SDS) before use.

Emergency Medical Assistance In case of inhalation, the affected individual should be removed to fresh air and kept comfortable for breathing. If the person feels unwell, it is important to contact a poison center or a physician. For skin exposure, thaw any frostbitten areas with lukewarm water without rubbing the affected area, and seek immediate medical advice or attention.

Side Effects

Administration of Nitrous Oxide may be associated with several adverse reactions, which can vary in seriousness and frequency.

Warnings Nitrous Oxide is contraindicated in certain situations and should only be administered by or under the supervision of a licensed practitioner experienced in its use. The administration of Nitrous Oxide may pose hazards, including the potential to cause or intensify fire, as it is an oxidizer. The gas is stored under pressure and may explode if heated. Patients may experience drowsiness or dizziness, and there is a risk of oxygen displacement leading to rapid suffocation. Additionally, exposure to the gas can result in frostbite.

Common Effects Among the common adverse reactions reported, drowsiness and dizziness are frequently observed in patients following the inhalation of Nitrous Oxide.

Risk of Frostbite Due to the properties of the gas, there is a notable risk of frostbite. In the event of inhalation, it is advised to remove the individual to fresh air and ensure they are comfortable for breathing. If the gas comes into contact with the skin, it is recommended to thaw any affected areas with lukewarm water without rubbing, and to seek immediate medical advice or attention.

In summary, while Nitrous Oxide can be effective for sedation, it is essential to be aware of the potential adverse reactions and to take appropriate precautions during its administration.

Drug Interactions

Administration of Nitrous Oxide may pose significant risks and is contraindicated in certain situations. Healthcare professionals should exercise caution when considering the use of Nitrous Oxide, as its administration could lead to hazardous outcomes.

No specific drug or laboratory test interactions have been identified in the available data. Therefore, routine monitoring or dosage adjustments related to drug or laboratory test interactions are not necessary at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrous Oxide Sedara (nitrous oxide), the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Administration of Nitrous Oxide may pose hazards or be contraindicated in pediatric patients. It is essential that Nitrous Oxide is used only by or under the supervision of a licensed practitioner who has experience in its use and administration, particularly in pediatric populations.

Safety precautions and monitoring are critical when administering Nitrous Oxide to children to ensure their well-being during the procedure.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients should be aware that this product contains a chemical known to the state of California to cause birth defects or other reproductive harm. The administration of Nitrous Oxide during pregnancy may pose risks and is considered hazardous or contraindicated. Healthcare professionals are advised to carefully evaluate the potential benefits and risks when considering the use of this product in pregnant patients. It is essential to discuss any concerns regarding fetal outcomes and to consider alternative options when necessary.

Lactation

The safety of Nitrous Oxide during lactation has not been explicitly addressed in the available data. Given that this product contains a chemical known to the state of California to cause birth defects or other reproductive harm, caution is advised when considering its use in lactating mothers.

Administration of Nitrous Oxide may pose hazards or be contraindicated, and it should only be used by or under the supervision of a licensed practitioner experienced in its use. Healthcare professionals should weigh the potential risks against the benefits when advising lactating mothers regarding the use of this product.

No specific data on excretion in breast milk or effects on breastfed infants are provided. Therefore, healthcare providers should exercise clinical judgment and consider alternative options when treating lactating patients.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of Nitrous Oxide Sedara. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for this patient population. It is recommended that healthcare providers exercise caution and consider the overall clinical context when administering this medication to patients with compromised liver function.

Overdosage

In the event of an overdosage, patients may present with a range of symptoms including drowsiness, dizziness, and in severe cases, rapid suffocation resulting from oxygen displacement. These symptoms necessitate prompt recognition and intervention.

Immediate medical attention is critical if an overdosage is suspected. Healthcare professionals should be prepared to assess the patient's condition and initiate appropriate management strategies.

It is important to note that the administration of Nitrous Oxide in cases of overdosage may pose significant risks and could be contraindicated. Therefore, it should only be administered under the supervision of a licensed practitioner who possesses the requisite experience in its use. This ensures that the patient receives the safest and most effective care possible during such an emergency.

Nonclinical Toxicology

This product contains a chemical known to the state of California to cause birth defects or other reproductive harm. No additional nonclinical toxicology data or specific animal pharmacology and toxicology information has been provided.

Postmarketing Experience

Postmarketing experience has revealed that the administration of Nitrous Oxide may be hazardous or contraindicated. Specific adverse reactions and safety updates related to Nitrous Oxide have not been detailed in the available data.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrous Oxide may pose hazards and is contraindicated in certain situations. It is essential that this substance is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. Patients should be informed that the practitioner must be familiar with the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be made aware of the potential dangers associated with Nitrous Oxide, including its ability to cause or intensify fire, as it is an oxidizer. They should be cautioned that it contains gas under pressure, which may explode if heated. Additionally, patients should be informed that Nitrous Oxide may cause drowsiness or dizziness, displace oxygen leading to rapid suffocation, and may cause frostbite.

It is crucial for patients to understand that they should not handle Nitrous Oxide until all safety precautions have been read and comprehended. They should be instructed to keep and store the gas away from clothing and other combustible materials, ensuring that valves and fittings remain free from grease and oil. Patients should be advised to avoid breathing the gas and to prevent contact with eyes, skin, or clothing.

Healthcare providers should emphasize the importance of using and storing Nitrous Oxide only outdoors or in a well-ventilated area. In the event of a fire, patients should be instructed to stop the leak if it is safe to do so. They should also be informed about the necessity of using a backflow preventive device in the piping and that only equipment made of compatible materials and rated for cylinder pressure should be utilized. Furthermore, patients should be advised to use equipment that has been cleaned for oxygen service.

Patients should be instructed to open the valve slowly and to close it after each use and when the cylinder is empty. They should also be cautioned to protect the gas from sunlight when the ambient temperature exceeds 52°C (125°F). Finally, healthcare providers should recommend that patients read and follow the Safety Data Sheet (SDS) before use to ensure their safety.

Storage and Handling

The product is available in various package configurations, with specific NDC numbers assigned for identification. Storage and handling instructions are not explicitly provided; therefore, standard practices for pharmaceutical products should be followed. It is advisable to store the product in a controlled environment, ensuring that it is kept at appropriate temperature ranges to maintain its integrity. Containers should be kept sealed and protected from light and moisture to prevent degradation. Special handling requirements are not specified, but general precautions should be taken to ensure the product's quality and safety during storage and transportation.

Additional Clinical Information

No further data are available.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrous Oxide Sedara as submitted by Linde Gas & Equipment Inc.. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)